scholarly journals Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer

2014 ◽  
Vol 45 (1) ◽  
pp. 12-18 ◽  
Author(s):  
H. Yamamoto ◽  
M. Ando ◽  
K. Aogi ◽  
H. Iwata ◽  
K. Tamura ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Pharmacokinetic Study ◽  
Metastatic Breast ◽  
Japanese Patients ◽  
Trastuzumab Emtansine ◽  
Her2 Positive

Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study

Breast Cancer ◽  
2018 ◽  
Vol 26 (1) ◽  
pp. 39-46 ◽  
Author(s):  
Emi Noguchi ◽  
Kenji Tamura ◽  
Masaya Hattori ◽  
Jun Horiguchi ◽  
Nobuaki Sato ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Japanese Patients ◽  
Trastuzumab Emtansine ◽  
Her2 Positive ◽  
Phase Ib

scholarly journals A Phase 2 Study of Trastuzumab Emtansine in Japanese Patients with HER2 Positive Metastatic Breast Cancer

2013 ◽  
Vol 24 ◽  
pp. ix20
Author(s):  
S. Takahashi ◽  
M. Kashiwaba ◽  
S. Takao ◽  
Y. Ito ◽  
H. Doihara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Japanese Patients ◽  
Trastuzumab Emtansine ◽  
Phase 2 ◽  
Her2 Positive ◽  
Phase 2 Study

Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy

2018 ◽  
Vol 171 (2) ◽  
pp. 371-381 ◽  
Author(s):  
Sarika Jain ◽  
Ami N. Shah ◽  
Cesar A. Santa-Maria ◽  
Kalliopi Siziopikou ◽  
Alfred Rademaker ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Trastuzumab Emtansine ◽  
Her2 Positive
Sign in / Sign up

Export Citation Format

Share Document